Otsuka Ties Up with UK’s PhoreMost, Initial Focus on Gene Therapy

January 22, 2020
Otsuka Pharmaceutical and UK biotech PhoreMost said on January 21 that they have concluded a multi-projection collaboration pact for the research and development of new drugs and diagnostics, hoping to mobilize their technologies initially with an eye to gene therapy...read more